GeneDx Announces Partnership with Komodo Health to Expand Access to World’s Largest Rare Disease Dataset

April 23, 2024

https://www.globenewswire.com/news-release/2024/04/23/2867664/0/en/GeneDx-Announces-Partnership-with-Komodo-Health-to-Expand-Access-to-World-s-Largest-Rare-Disease-Dataset.html

STAMFORD, Conn., April 23, 2024 (GLOBE NEWSWIRE) — GeneDx (Nasdaq:WGS), a leader in delivering improved health outcomes through genomic insights, today announced a strategic partnership with Komodo Health, a premier healthcare technology company for the pharmaceutical industry. The new partnership will increase access to GeneDx’s extensive de-identified rare disease data set, now available through Komodo Health’s MapEnhance offering, including data from more than 500,000 exomes, enabling biopharma companies to access genetic insights that can help inform drug pipelines and accelerate clinical trial enrollment.

Read more at globenewswire.com

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.